SI1031575T1 - Process for preparing growth hormone secretagogues - Google Patents

Process for preparing growth hormone secretagogues

Info

Publication number
SI1031575T1
SI1031575T1 SI200030502T SI200030502T SI1031575T1 SI 1031575 T1 SI1031575 T1 SI 1031575T1 SI 200030502 T SI200030502 T SI 200030502T SI 200030502 T SI200030502 T SI 200030502T SI 1031575 T1 SI1031575 T1 SI 1031575T1
Authority
SI
Slovenia
Prior art keywords
growth hormone
hormone secretagogues
preparing growth
preparing
secretagogues
Prior art date
Application number
SI200030502T
Other languages
English (en)
Slovenian (sl)
Inventor
Frank Robert Busch
Charles Kwok-Fung Chiu
Clifford Nathaniel Meltz
Ronald James Post
Peter Robert Rose
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of SI1031575T1 publication Critical patent/SI1031575T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
SI200030502T 1999-02-26 2000-02-25 Process for preparing growth hormone secretagogues SI1031575T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12274599P 1999-02-26 1999-02-26
EP00301526A EP1031575B1 (en) 1999-02-26 2000-02-25 Process for preparing growth hormone secretagogues

Publications (1)

Publication Number Publication Date
SI1031575T1 true SI1031575T1 (en) 2005-02-28

Family

ID=22404505

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030502T SI1031575T1 (en) 1999-02-26 2000-02-25 Process for preparing growth hormone secretagogues

Country Status (44)

Country Link
US (2) US6541634B2 (ko)
EP (2) EP1449842A1 (ko)
JP (3) JP3437813B2 (ko)
KR (2) KR100372063B1 (ko)
CN (3) CN1837205A (ko)
AP (1) AP1221A (ko)
AR (2) AR029617A1 (ko)
AT (1) ATE277944T1 (ko)
AU (1) AU764122B2 (ko)
BG (1) BG104175A (ko)
BR (2) BRPI0017522B8 (ko)
CA (1) CA2299495C (ko)
CO (1) CO5160252A1 (ko)
DE (1) DE60014212T2 (ko)
DK (1) DK1031575T3 (ko)
DZ (1) DZ3018A1 (ko)
EA (1) EA003218B1 (ko)
EE (1) EE200000193A (ko)
ES (1) ES2226712T3 (ko)
GT (1) GT200000018A (ko)
HK (1) HK1030219A1 (ko)
HN (1) HN2000000021A (ko)
HR (1) HRP20000103A2 (ko)
HU (1) HUP0000907A3 (ko)
ID (1) ID24861A (ko)
IL (2) IL157103A (ko)
IN (1) IN192352B (ko)
IS (1) IS5380A (ko)
MA (1) MA25072A1 (ko)
NO (1) NO20000965L (ko)
NZ (1) NZ503062A (ko)
OA (1) OA11325A (ko)
PA (1) PA8491201A1 (ko)
PE (1) PE20001550A1 (ko)
PL (1) PL338628A1 (ko)
PT (1) PT1031575E (ko)
SG (1) SG90096A1 (ko)
SI (1) SI1031575T1 (ko)
SK (1) SK284982B6 (ko)
TN (1) TNSN00035A1 (ko)
TR (1) TR200000536A2 (ko)
TW (2) TWI286142B (ko)
UA (1) UA70306C2 (ko)
ZA (1) ZA200000888B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1132388A3 (en) * 2000-03-09 2004-03-03 Pfizer Products Inc. Hexahydropyrazolo[4,3-c]pyridine metabolites
WO2001091752A1 (en) 2000-05-30 2001-12-06 Merck & Co., Inc. Melanocortin receptor agonists
AU2003237595A1 (en) * 2003-05-26 2004-12-13 Biocon Limited Process for the preparation of s(+)-2-ethoxy-4-(n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl)benzoic acid derivatives
WO2005027913A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
US9117477B2 (en) 2013-05-08 2015-08-25 HGST Netherlands B.V. Perpendicular magnetic recording media having novel seed layer
WO2014192294A1 (en) * 2013-05-28 2014-12-04 Raqualia Pharma Inc. Polymorph forms
CN109320515A (zh) * 2018-11-22 2019-02-12 常州大学 一种Capromorelin手性中间体的不对称合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610980D0 (en) 1986-05-06 1986-06-11 Ici America Inc Heterocyclic fused tricyclic compounds
GB8901423D0 (en) 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
US5536716A (en) 1992-12-11 1996-07-16 Merck & Co., Inc. Spiro piperidines and homologs which promote release of growth hormone
PL322706A1 (en) 1993-11-09 1998-02-16 Merck & Co Inc Piperidines, pyrolidines and hexahydro-1h-azepins enhancing growth hormone liberation
US5609150A (en) 1995-04-18 1997-03-11 Maged; Jeffrey M. Method for dilating respiratory passages
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
WO1997034604A1 (en) 1996-03-21 1997-09-25 Merck & Co., Inc. 4-spiroindoline piperidines promote release of growth hormone
WO1997036873A1 (en) 1996-04-03 1997-10-09 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
UA64751C2 (uk) * 1997-06-25 2004-03-15 Пфайзер Продактс Інк. Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти)
JP3514774B2 (ja) 1997-06-25 2004-03-31 ファイザー・インク 成長ホルモン分泌促進薬としてのジペプチド誘導体
UA53716C2 (uk) 1997-06-25 2003-02-17 Пфайзер Продактс Інк. Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)

Also Published As

Publication number Publication date
NO20000965L (no) 2000-08-28
KR100372063B1 (ko) 2003-02-14
SK284982B6 (sk) 2006-03-02
EA200000172A2 (ru) 2000-08-28
EA200000172A3 (ru) 2000-10-30
IN192352B (ko) 2004-04-10
BRPI0000967B8 (pt) 2021-12-07
HK1030219A1 (en) 2001-04-27
AP2000001754A0 (en) 2000-03-31
MA25072A1 (fr) 2000-10-01
BRPI0017522B1 (pt) 2013-09-24
JP4051314B2 (ja) 2008-02-20
BRPI0000967A (pt) 2001-09-11
EP1031575A1 (en) 2000-08-30
SG90096A1 (en) 2002-07-23
DE60014212D1 (de) 2004-11-04
US20030158414A1 (en) 2003-08-21
EE200000193A (et) 2000-10-16
EP1031575B1 (en) 2004-09-29
US6673929B2 (en) 2004-01-06
TWI286142B (en) 2007-09-01
BRPI0017522B8 (pt) 2021-05-25
ATE277944T1 (de) 2004-10-15
HU0000907D0 (en) 2000-04-28
PA8491201A1 (es) 2001-04-30
SK2302000A3 (en) 2000-11-07
BRPI0000967B1 (pt) 2012-06-12
TR200000536A2 (tr) 2000-09-21
JP2003327585A (ja) 2003-11-19
JP2000247974A (ja) 2000-09-12
US20020002283A1 (en) 2002-01-03
JP3437813B2 (ja) 2003-08-18
GT200000018A (es) 2001-08-16
TW200718702A (en) 2007-05-16
CA2299495C (en) 2010-06-15
HRP20000103A2 (en) 2001-04-30
JP2003261565A (ja) 2003-09-19
PE20001550A1 (es) 2001-01-11
IL157103A0 (en) 2004-02-08
KR20020065455A (ko) 2002-08-13
KR100361783B1 (ko) 2002-11-22
IL134599A0 (en) 2001-04-30
ZA200000888B (en) 2001-08-23
AR053722A2 (es) 2007-05-16
BRPI0017522A2 (ko) 2009-12-22
CN1515570A (zh) 2004-07-28
CO5160252A1 (es) 2002-05-30
BG104175A (bg) 2000-12-29
ES2226712T3 (es) 2005-04-01
CA2299495A1 (en) 2000-08-26
NO20000965D0 (no) 2000-02-25
OA11325A (en) 2003-10-27
EP1449842A1 (en) 2004-08-25
AU1947100A (en) 2000-08-31
IL157103A (en) 2007-07-24
CN1837205A (zh) 2006-09-27
AR029617A1 (es) 2003-07-10
CN1137891C (zh) 2004-02-11
IL134599A (en) 2006-12-10
KR20010006698A (ko) 2001-01-26
EA003218B1 (ru) 2003-02-27
TNSN00035A1 (fr) 2005-11-10
IS5380A (is) 2000-08-27
PL338628A1 (en) 2000-08-28
US6541634B2 (en) 2003-04-01
PT1031575E (pt) 2004-11-30
HUP0000907A3 (en) 2001-05-28
HUP0000907A2 (en) 2001-03-28
NZ503062A (en) 2001-07-27
ID24861A (id) 2000-08-31
DZ3018A1 (fr) 2004-03-20
AP1221A (en) 2003-11-03
CN1270960A (zh) 2000-10-25
AU764122B2 (en) 2003-08-07
HN2000000021A (es) 2001-02-02
DK1031575T3 (da) 2005-01-03
UA70306C2 (en) 2004-10-15
DE60014212T2 (de) 2005-12-15

Similar Documents

Publication Publication Date Title
EP1229125A4 (en) PROCESS FOR PRODUCING A POLYPEPTIDE
HUP0203206A3 (en) Process for preparing 4-trifluoromethylsulphinylpyrazole derivative
IL153067A0 (en) Growth hormone secretagogues
IL126264A0 (en) Process for preparing lactic acid
IL154115A0 (en) Process for the preparation of growth hormone secretagogues
IL147253A0 (en) Growth hormone formulations
IL144350A0 (en) Growth hormone secretagogues
HU9904384D0 (en) Process and intermediates for growth hormone secretagogues
IL144697A0 (en) Microbial process for preparing paravastatin
EP1158996A4 (en) NEW AMID DERIVATIVES AS GROWTH HORMONE SECRETION CONVEYORS
HK1030219A1 (en) Process for preparing growth hormone secretagogues
EP1243657A4 (en) PROCESS FOR THE PRODUCTION OF GLYCIN
IL145791A0 (en) Process for preparing mkc-442
EP1089978A4 (en) METHOD FOR PRODUCING OXIMIDAZOLES
EG22139A (en) Process for preparing 4- substituted-1H-indole -3- glyoxamides
HUP0000559A3 (en) Process for preparing cyanoaceticacidesters
GB9926266D0 (en) Plant growth apparatus
EG21526A (en) Improved process for preparing pharmaceutically useful norbenzomorphane derivatives
EP1112071A4 (en) SECRETAGOGUES OF GROWTH HORMONES
GB9908662D0 (en) Novel process for preparing benzodiazepines
IL135809A0 (en) Process for preparing 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4h-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
EP1119549A4 (en) PROCESS FOR THE PREPARATION OF SUBSTITUTED 4-1H-INDOLE-3-GLYOXAMIDES
GB9916252D0 (en) Growth hormone formulation
GB9809786D0 (en) Process for preparing 4-tert-Butyloxycarbonyl-(S)-piperazine-2-tert-butylcarboxamide
GB9901721D0 (en) Process for preparing 4-tert-Butyloxycarbonyl-(S)-piperazine-2-tert-butylcarboxamide